v3.22.2.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development $ 151 $ 328 $ 1,959 $ 586
General and administrative 454 623 1,509 1,366
Loss from operations (605) (951) (3,468) (1,952)
Interest income (1) (2) (3) (5)
Net Loss $ (604) $ (949) $ (3,465) $ (1,947)
Net loss per common share outstanding, basic $ (0.03) $ (0.06) $ (0.16) $ (0.12)
Net loss per common share outstanding, diluted $ (0.03) $ (0.06) $ (0.16) $ (0.12)
Weighted average number of common shares outstanding, basic 21,916,005 16,556,320 21,439,242 16,556,320
Weighted average number of common shares outstanding, diluted 21,916,005 16,556,320 21,439,242 16,556,320

Source